XML 30 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2016
Dec. 31, 2018
Cash equivalents, at carrying value    
Payments to acquire marketable securities $ 1,429,668    
Proceeds from sale of marketable securities 250,000 1,635,000    
Marketable securities, gross realized (gain) loss 4,435 784    
Marketable securities, gross unrealized gain (loss) 0      
Marketable securities 0     $ 250,388
Derivative, gain (loss) on derivative, net $ 49,402 $ 6,160    
Measurement Input, Expected Dividend Rate [Member]        
Fair value measurements, input percentage 0.00%      
Private Placement [Member] | Series B Preferred Stock [Member]        
Class of warrant or right, issued     127,346  
Private Placement [Member] | Placement Agent Warrants [Member] | Series B Preferred Stock [Member]        
Class of warrant or right, issued 127,346      
Private Placement [Member] | Debt Settlement [Member] | Series B Preferred Stock [Member] | Strategic Bio Partners [Member]        
Class of warrant or right, issued 295,945      
Equipment [Member]        
Property, plant and equipment, useful life 3 years